Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer (Record no. 25970)

000 -LEADER
fixed length control field 01732pab a2200277 454500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150901b2005 xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency Tata Memorial Hospital
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number
Item number Oh,/Par
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Oh, S. C.
245 ## - TITLE STATEMENT
Title Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc. 2005
300 ## - PHYSICAL DESCRIPTION
Extent 827-831
490 ## - SERIES STATEMENT
Series statement
Volume/sequential designation Vol 92 Issues 5
520 ## - SUMMARY, ETC.
Summary, etc. We conducted this study to ascertain the efficacy and toxicity of docetaxel and cisplatin combined with oral UFT and leucovorin as a first-line treatment for patients with advanced gastric cancer. In all, 52 patients received courses of docetaxel 60 mg m-2 intravenously (i.v.) for 1 h and then cisplatin 75 mg m-2 i.v. for 2 h on day 1. Oral UFT at 400-600 mg day-1, as determined by body surface area, and leucovorin at 75 mg day-1 were administered for 21 consecutive days from day 1, and this was followed by a 7-day drug-free interval. A total of 225 courses were administered, and the median number of courses per patient was four. Four complete responses (7.7%) and 22 partial responses (42.3%) were achieved, giving an overall response rate of 50% (95% Confidence Interval: 36.4-63.6%). The major toxicity was neutropenia, which reached grade 3/4 in 36 patients (69.3%). Grade 3/4 nausea and vomiting was observed in 12 patients (23.1%). Median time to progression was 22 weeks (4 to 156+ weeks), median survival d
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element stomach neoplasms,,
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element UFT
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element cisplatin
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element docetaxel
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Choi, I. K.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Park, K. H.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name
773 ## - HOST ITEM ENTRY
Host Biblionumber 78035
Main entry heading British Journal of Cancer
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a Mar
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Cost, normal purchase price Full call number Barcode Date last seen Price effective from Koha item type
        Tata Memorial Hospital Tata Memorial Hospital 2015-09-02 0.00 Oh,/Par AR5645 2015-09-02 2015-09-02 Articles

Powered by Koha